Revance Shares Jump 18% After FDA Approves Botox Rival Daxxify
Topline Shares of Revance Therapeutics surged 18% Thursday after the corporate introduced the Meals and Drug Administration had accepted Daxxify, ...
Tag: Botox
Topline Shares of Revance Therapeutics surged 18% Thursday after the corporate introduced the Meals and Drug Administration had accepted Daxxify, ...
